Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

440 public trials 66 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Active, not recruiting

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed

NCT02935361

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Active, not recruiting

Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes

NCT04802161

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemia With Multilineage Dysplasia, +19 more
Locations
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

AZD6738 for Patients With Progressive MDS or CMML

NCT03770429

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • BIDMC Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details

Related conditions